Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery. [electronic resource]
Producer: 20131022Description: 359-66 p. digitalISSN:- 1940-4034
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Aorta, Thoracic
- Becaplermin
- Carotid Artery Injuries -- drug therapy
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- DNA Replication -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- drug effects
- Heparin-binding EGF-like Growth Factor
- Humans
- Hyperplasia -- prevention & control
- In Vitro Techniques
- Indoles -- pharmacology
- Intercellular Signaling Peptides and Proteins -- physiology
- Male
- Muscle, Smooth, Vascular -- drug effects
- Neointima -- prevention & control
- Phosphorylation -- drug effects
- Platelet-Derived Growth Factor -- pharmacology
- Proto-Oncogene Proteins c-sis -- pharmacology
- Pyrroles -- pharmacology
- Rats
- Rats, Wistar
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.